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Abstract
Pandemics over the years have been a constant threat towards mankind, the most recent COVID-19 outbreak is no exception 
to this. With the emerging demand of treating the outbreak, majority of the frontline workers have been assigned towards 
helping out the COVID-19 affected patients leaving the others behind. However, over time several healthcare practitioners 
have been using alternative forms of patient assessment tools. Heath Related Quality of Life (HRQOL) is one of the commonly 
used tools that have been widely used across Europe and America, using these, patients can self-evaluate their own conditions 
without requiring the assistance of a doctor. This paper focuses provides a conceptual framework that can be followed for 
quality of life assessment in chronic kidney patients using the Kidney Disease Quality of Life (KDQOL) questionnaire.
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Introduction
Heath Related Quality of Life (HRQOL) is defined as 
the awareness of an individuals’ status in life and his/her 
relationship with the surroundings he/she lives. HRQOL is 
becoming a significant tool in patients suffering from chronic 
diseases in order to evaluate the responses of a treatment and 
adjust the treatment options based on individuals’ physical, 
emotional and social requirements. HRQOL is assessed in 
patients though different types of assessing methods namely, 
the Dartmouth COOP Functional Assessment Charts, Duke 
Health Profile, Health Assessment Questionnaire, Nottingham 
Health Profile (NHP), 12-Item Short Form Health Survey (SF-
12), 36-Item Short Form Health Survey (SF-36), Sickness 
Impact Profile and the World Health Organization Quality of 
Life Scale (WHOQOL-100). Accordingly, SF-36 is the method 
used more often for assessing HRQOL in a more general view.
The SF-36 is questionnaire that consists of 36 items 
which includes 8 subscales and 2 component scores and 
evaluates physical, mental and social well-being along with 
psychological state and general health using a set of standard 
questions. One such chronic disease which relies on QOL, 
specifically on the Kidney Disease Quality of Life (KDQOL) 
is the Chronic Kidney Disease (CKD). CKD is a condition 
where there is a progressive kidney failure through five 
important stages that are named from stage one to five 
which usually results due to common causes like diabetes 
and hypertension or otherwise due to aging and obesity and 
results in complications like hyperlipidemia, cardiovascular 
risk, anemia, decreased quality of life, premature mortality 
and metabolic bone disease.
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The specific type of questionnaire used to assess CKD 
is called the KDQOL-SF which includes the questions of 
SF-36 along with a set of chronic kidney disease specific 
dimensions. It contains 12 scales to describe 43 items which 
includes the symptoms, effects of kidney disease, burden 
of kidney disease, work status, cognitive function, quality 
of social interaction, sexual function, sleep, Social support, 
dialysis staff support, overall health and patient satisfaction. 
Thus, the state and effect of CKD can be deeply assessed 
based on the personal perspective of each patient.
Some studies have already proven that KDQOL-SF is a 
worthy tool, for example a study by Senanayake, et al.  used 
a modified version of a KDQOL questionnaire at renal clinics 
in Polonnaruwa and concluded that the questionnaire is a 
valid and reliable method of assessing CKD patients in Sri 
Lanka. Another research by Cruz, et al. concluded that CKD 
patients show a decreased QOL in early stages of disease 
but the association between QOL and each stage of CKD is 
unpredictable.
But since early 1990s, CKD irrelated to its’ general 
causes have been noticed in some regions of Sri Lanka, 
specifically in the North Central Region and it is termed as 
the Chronic Kidney Disease of unknown etiology (CKDu). The 
possible causes are still in research and some scientists have 
suggested the probable factors to be nephrotoxins like heavy 
metals (cadmium), bacterial toxins (cyanotoxin) and fungal 
toxins (Ochratoxin A) that are found in the agricultural lands 
and contaminated water bodies.
Unlike CKD, CKDu is a condition which is asymptomatic 
during the initial stages and shows symptoms like fatigue, 
panting, loss of appetite, nausea, hypertension and edema 
only at the latter stages of disease, due to this finding a cure 
for this disease is complicated. Thereby patients are treated 
for the signs and symptoms only.  And to our knowledge, 
there is no data on the reliability on KDQOL for assessing 
CKDu like CKD is being assessed.
Therefore, in this cross-sectional study, the use of KDQOL 
for assessing CKDu is tested using a KDQOL questionnaire so 
that if the QOL of these CKDu patients is associated with their 
disease, then KDQOL can be used to monitor and treat these 
patients in an efficient and cost-effective manner.
